Table 5.
Group | Number of cases | SF-36 scores | t | P | |
---|---|---|---|---|---|
| |||||
Before treatment | After treatment | ||||
Observation group | 56 | 55.97±4.26 | 73.43±5.59 | 18.591 | 0.000 |
Control group | 56 | 56.54±4.48 | 66.06±5.22 | 10.357 | 0.000 |
t | 0.690 | 7.211 | |||
P | 0.492 | 0.000 |
Group | Number of cases | SF-36 scores | t | P | |
---|---|---|---|---|---|
| |||||
Before treatment | After treatment | ||||
Observation group | 56 | 55.97±4.26 | 73.43±5.59 | 18.591 | 0.000 |
Control group | 56 | 56.54±4.48 | 66.06±5.22 | 10.357 | 0.000 |
t | 0.690 | 7.211 | |||
P | 0.492 | 0.000 |